Spain· ES:81969
BLEOMICINA ACCORD 15.000 UI POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG
A medicinal product containing bleomicina, registered in Spain by Accord Healthcare S.L.U..
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- bleomicina
- Manufacturer
- Accord Healthcare S.L.U.
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bleomicina in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyBleo-CellStadapharm Gmbh
- NetherlandsBleomedac, poeder voor oplossing voor injectie 15000 IU (Ph. Eur.)Medac Gesellschaft für klinische Spezialpräparate mbH
- United KingdomBleo-Kyowa 15,000unit powder for solution for injection vialsKyowa Kirin Ltd
- SwedenBleomycin Accord 15000 IE Pulver till injektions-/infusionsvätska, lösningAccord Healthcare B.V.
- SwitzerlandBleomycin Baxter
- FranceBLEOMYCINE ACCORD 15000 UI, poudre pour solution injectable / pour perfusionACCORD HEALTHCARE FRANCE
- CanadaBLEOMYCIN FOR INJECTIONFRESENIUS KABI CANADA LTD
- NorwayBleomycin BaxterBaxter Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Bleomycin Accord, Bleomycin Baxter
- Belgium · Bleomycine Accord
- Czechia · Bleomycin Accord
- Germany · Bleo-Cell, Bleomycin Accord
- Denmark · Bleomycin Accord, Bleomycin Baxter
- Finland · Bleomycin Accord
- France · Bleomycine Accord
- United Kingdom (Northern Ireland) · Bleomycin, Bleomycin Accord Healthcare
- Iceland · Bleomycin Baxter
- Netherlands · Bleomycine Accord
- Norway · Bleomycin Accord, Bleomycin Baxter
- Poland · Bleomedac, Bleomycyna
- Portugal · Bleomicina Accord
- Romania · Bleomicină Accord
- Sweden · Bleomycin Accord, Bleomycin Baxter
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3719c57-05ef-44f4-a8cb-34203b67167d GET /v1/drugs/e3719c57-05ef-44f4-a8cb-34203b67167d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1492466400000,\"susp\":1718355908000}",
"nregistro": "81969",
"substance": "bleomicina"
}See everything about bleomicina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.